Oxandrolone in trauma patients

Jane M. Gervasio, Roland Dickerson, Jessica Swearingen, Mary E.D. Yates, Ceaminia Yuen, Timothy Fabian, Martin Croce, Rex Brown

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Study Objective. To determine the effect of oxandrolone administration on nutritional and clinical outcomes after multiple trauma. Design. Prospective, randomized, double-blind, placebo-controlled study. Setting. Level 1 trauma center in a university teaching hospital. Patients. Sixty-two patients requiring enteral nutrition, 60 of whom completed the study. Intervention. Patients were randomized to receive either oxandrolone 10 mg or placebo twice/day for a maximum of 28 days. Measurements and Main Results. Total urinary nitrogen, prealbumin, nitrogen balance, total body water, and body cell mass were measured on day 1 of enteral nutrition and then at day 7, day 10, and study exit. Patients were assessed daily for metabolic and infectious complications. The two groups were similar for demographics and dosage of enteral nutrition. Measurement of total urinary nitrogen at study entry showed both groups to be highly catabolic (oxandrolone 17.2 ± 4.9, placebo 19.1 ± 10.8 g/day, NS). On days 7 and 10, total urinary nitrogen increased in both groups; however, there was no significant difference between groups. Nitrogen balance was negative throughout the study in each group. Body cell mass decreased slightly in both groups over the study period. Prealbumin serum concentrations increased significantly in both groups at day 10 and study exit compared with study entry. The groups did not differ significantly for length of hospital stay (oxandrolone 30.8 ± 17.9, placebo 27.0 ± 25.7 days), length of intensive care unit stay (oxandrolone 17.1 ± 7.8, placebo 15.5 ± 9.7 days), and frequency of pneumonia or sepsis (oxandrolone 48, placebo 43 episodes). Conclusion. Oxandrolone 20 mg/day does not have obvious benefit in nutritional and clinical outcomes during the first month after multiple trauma.

Original languageEnglish (US)
Pages (from-to)1328-1334
Number of pages7
JournalPharmacotherapy
Volume20
Issue number11
DOIs
StatePublished - Jan 1 2000

Fingerprint

Oxandrolone
Placebos
Nitrogen
Wounds and Injuries
Enteral Nutrition
Prealbumin
Multiple Trauma
Length of Stay
Body Water
Trauma Centers
Teaching Hospitals
Intensive Care Units
Sepsis
Pneumonia
Demography

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Gervasio, J. M., Dickerson, R., Swearingen, J., Yates, M. E. D., Yuen, C., Fabian, T., ... Brown, R. (2000). Oxandrolone in trauma patients. Pharmacotherapy, 20(11), 1328-1334. https://doi.org/10.1592/phco.20.17.1328.34889

Oxandrolone in trauma patients. / Gervasio, Jane M.; Dickerson, Roland; Swearingen, Jessica; Yates, Mary E.D.; Yuen, Ceaminia; Fabian, Timothy; Croce, Martin; Brown, Rex.

In: Pharmacotherapy, Vol. 20, No. 11, 01.01.2000, p. 1328-1334.

Research output: Contribution to journalArticle

Gervasio, JM, Dickerson, R, Swearingen, J, Yates, MED, Yuen, C, Fabian, T, Croce, M & Brown, R 2000, 'Oxandrolone in trauma patients', Pharmacotherapy, vol. 20, no. 11, pp. 1328-1334. https://doi.org/10.1592/phco.20.17.1328.34889
Gervasio JM, Dickerson R, Swearingen J, Yates MED, Yuen C, Fabian T et al. Oxandrolone in trauma patients. Pharmacotherapy. 2000 Jan 1;20(11):1328-1334. https://doi.org/10.1592/phco.20.17.1328.34889
Gervasio, Jane M. ; Dickerson, Roland ; Swearingen, Jessica ; Yates, Mary E.D. ; Yuen, Ceaminia ; Fabian, Timothy ; Croce, Martin ; Brown, Rex. / Oxandrolone in trauma patients. In: Pharmacotherapy. 2000 ; Vol. 20, No. 11. pp. 1328-1334.
@article{6fffc0899ae545bf9dd846a8294a7f1b,
title = "Oxandrolone in trauma patients",
abstract = "Study Objective. To determine the effect of oxandrolone administration on nutritional and clinical outcomes after multiple trauma. Design. Prospective, randomized, double-blind, placebo-controlled study. Setting. Level 1 trauma center in a university teaching hospital. Patients. Sixty-two patients requiring enteral nutrition, 60 of whom completed the study. Intervention. Patients were randomized to receive either oxandrolone 10 mg or placebo twice/day for a maximum of 28 days. Measurements and Main Results. Total urinary nitrogen, prealbumin, nitrogen balance, total body water, and body cell mass were measured on day 1 of enteral nutrition and then at day 7, day 10, and study exit. Patients were assessed daily for metabolic and infectious complications. The two groups were similar for demographics and dosage of enteral nutrition. Measurement of total urinary nitrogen at study entry showed both groups to be highly catabolic (oxandrolone 17.2 ± 4.9, placebo 19.1 ± 10.8 g/day, NS). On days 7 and 10, total urinary nitrogen increased in both groups; however, there was no significant difference between groups. Nitrogen balance was negative throughout the study in each group. Body cell mass decreased slightly in both groups over the study period. Prealbumin serum concentrations increased significantly in both groups at day 10 and study exit compared with study entry. The groups did not differ significantly for length of hospital stay (oxandrolone 30.8 ± 17.9, placebo 27.0 ± 25.7 days), length of intensive care unit stay (oxandrolone 17.1 ± 7.8, placebo 15.5 ± 9.7 days), and frequency of pneumonia or sepsis (oxandrolone 48, placebo 43 episodes). Conclusion. Oxandrolone 20 mg/day does not have obvious benefit in nutritional and clinical outcomes during the first month after multiple trauma.",
author = "Gervasio, {Jane M.} and Roland Dickerson and Jessica Swearingen and Yates, {Mary E.D.} and Ceaminia Yuen and Timothy Fabian and Martin Croce and Rex Brown",
year = "2000",
month = "1",
day = "1",
doi = "10.1592/phco.20.17.1328.34889",
language = "English (US)",
volume = "20",
pages = "1328--1334",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Oxandrolone in trauma patients

AU - Gervasio, Jane M.

AU - Dickerson, Roland

AU - Swearingen, Jessica

AU - Yates, Mary E.D.

AU - Yuen, Ceaminia

AU - Fabian, Timothy

AU - Croce, Martin

AU - Brown, Rex

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Study Objective. To determine the effect of oxandrolone administration on nutritional and clinical outcomes after multiple trauma. Design. Prospective, randomized, double-blind, placebo-controlled study. Setting. Level 1 trauma center in a university teaching hospital. Patients. Sixty-two patients requiring enteral nutrition, 60 of whom completed the study. Intervention. Patients were randomized to receive either oxandrolone 10 mg or placebo twice/day for a maximum of 28 days. Measurements and Main Results. Total urinary nitrogen, prealbumin, nitrogen balance, total body water, and body cell mass were measured on day 1 of enteral nutrition and then at day 7, day 10, and study exit. Patients were assessed daily for metabolic and infectious complications. The two groups were similar for demographics and dosage of enteral nutrition. Measurement of total urinary nitrogen at study entry showed both groups to be highly catabolic (oxandrolone 17.2 ± 4.9, placebo 19.1 ± 10.8 g/day, NS). On days 7 and 10, total urinary nitrogen increased in both groups; however, there was no significant difference between groups. Nitrogen balance was negative throughout the study in each group. Body cell mass decreased slightly in both groups over the study period. Prealbumin serum concentrations increased significantly in both groups at day 10 and study exit compared with study entry. The groups did not differ significantly for length of hospital stay (oxandrolone 30.8 ± 17.9, placebo 27.0 ± 25.7 days), length of intensive care unit stay (oxandrolone 17.1 ± 7.8, placebo 15.5 ± 9.7 days), and frequency of pneumonia or sepsis (oxandrolone 48, placebo 43 episodes). Conclusion. Oxandrolone 20 mg/day does not have obvious benefit in nutritional and clinical outcomes during the first month after multiple trauma.

AB - Study Objective. To determine the effect of oxandrolone administration on nutritional and clinical outcomes after multiple trauma. Design. Prospective, randomized, double-blind, placebo-controlled study. Setting. Level 1 trauma center in a university teaching hospital. Patients. Sixty-two patients requiring enteral nutrition, 60 of whom completed the study. Intervention. Patients were randomized to receive either oxandrolone 10 mg or placebo twice/day for a maximum of 28 days. Measurements and Main Results. Total urinary nitrogen, prealbumin, nitrogen balance, total body water, and body cell mass were measured on day 1 of enteral nutrition and then at day 7, day 10, and study exit. Patients were assessed daily for metabolic and infectious complications. The two groups were similar for demographics and dosage of enteral nutrition. Measurement of total urinary nitrogen at study entry showed both groups to be highly catabolic (oxandrolone 17.2 ± 4.9, placebo 19.1 ± 10.8 g/day, NS). On days 7 and 10, total urinary nitrogen increased in both groups; however, there was no significant difference between groups. Nitrogen balance was negative throughout the study in each group. Body cell mass decreased slightly in both groups over the study period. Prealbumin serum concentrations increased significantly in both groups at day 10 and study exit compared with study entry. The groups did not differ significantly for length of hospital stay (oxandrolone 30.8 ± 17.9, placebo 27.0 ± 25.7 days), length of intensive care unit stay (oxandrolone 17.1 ± 7.8, placebo 15.5 ± 9.7 days), and frequency of pneumonia or sepsis (oxandrolone 48, placebo 43 episodes). Conclusion. Oxandrolone 20 mg/day does not have obvious benefit in nutritional and clinical outcomes during the first month after multiple trauma.

UR - http://www.scopus.com/inward/record.url?scp=0033754587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033754587&partnerID=8YFLogxK

U2 - 10.1592/phco.20.17.1328.34889

DO - 10.1592/phco.20.17.1328.34889

M3 - Article

VL - 20

SP - 1328

EP - 1334

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 11

ER -